Paratek To Acquire Optinose, Expanding Portfolio Beyond Antibiotics

 
• By Joseph Haas
  
merger and acquisition business concepts, join company on puzzle pieces, 3d rendering
Paratek will acquire Optinose and CRS drug Xhance

More from Deals

More from Therapy Areas